Implementing Personalized Cancer Medicine: Insights from a Qualitative Interview Study

Area of Science:

• Oncology
• Healthcare Management
• Genomics

Background:

• Personalized cancer medicine (PCM) offers tailored treatments based on genetic profiles.
• Integration into clinical practice is hindered by organizational and systemic barriers.
• This study investigates PCM implementation factors at a leading Swedish cancer center.

Purpose of the Study:

• To identify barriers and facilitators influencing the implementation of personalized cancer medicine.
• To explore the perspectives of healthcare professionals and management on PCM integration.
• To inform strategies for successful PCM adoption in clinical settings.

Main Methods:

• Semi-structured interviews were conducted with 16 medical professionals and management staff.
• Content analysis was employed to identify key themes related to PCM implementation.
• Qualitative research guidelines (COREQ) ensured methodological rigor.

Main Results:

• PCM is viewed as both a technological innovation and a patient-centered approach.
• Identified barriers include organizational inertia, funding fragmentation, and equity concerns.
• Facilitators include leadership commitment, cross-sectoral collaboration, and supportive policies.

Conclusions:

• Successful PCM implementation necessitates overcoming systemic barriers via multi-stakeholder collaboration.
• A "third-form organization" is proposed to bridge academia and clinical care.
• Adaptive governance, policy reform, and sustainable funding are crucial for PCM integration.